[The challenges of managing thoracic pain in cystic fibrosis (CF)]

A T Hoffmann1, S Dillenhöfer1, T Lücke1

  • 1Universitätsklinik für Kinder- und Jugendmedizin, Ruhr-Universität Bochum, Alexandrinenstraße 5, 44791, Bochum, Deutschland.

Schmerz (Berlin, Germany)
|November 11, 2021
PubMed

Insights

Pain management in cystic fibrosis (CF) is underestimated. Current German guidelines lack pain management protocols, necessitating an interdisciplinary approach for effective thoracic pain relief in CF patients.

Area of Science:

  • Medical research
  • Pulmonology
  • Pain management

Background:

  • Cystic Fibrosis (CF) is a rare genetic disorder causing progressive multi-systemic complications.
  • Pain is a frequently underestimated symptom in CF patients, impacting quality of life.
  • Abdominal and pulmonary involvement are characteristic, often exacerbating pain experiences.

Approach:

  • A comprehensive literature review of existing guidelines and scientific publications on pain management in CF was conducted.
  • Clinical findings from a young CF patient experiencing progressive thoracic pain were integrated.
  • The review focused on identifying gaps in current pain management strategies within CF care.

Key Points:

  • German CF guidelines do not currently address the diagnosis and management of pain.
  • International studies indicate a correlation between pain intensity and mortality in CF.
  • Data on the efficacy of specific pain management interventions in CF are limited.
  • Managing pain in CF presents unique challenges due to multi-organ involvement.

Conclusions:

  • Pain management in CF necessitates meticulous monitoring and an interdisciplinary strategy.
  • Recommendations for treating thoracic pain in CF are proposed.
  • The complexity of organ involvement in CF complicates the use of both opioid and non-opioid analgesics.
  • Opioid therapy in CF patients requires close medical supervision due to risks like hypoxia and opioid-induced constipation (OIC).
Abstract

Related Concept Videos

Cystic Fibrosis: Management01:24

Cystic Fibrosis: Management

Cystic fibrosis (CF) is an autosomal recessive disorder that predominantly affects individuals of Northern European descent, occurring at a rate of 1 in 3500. It is caused by a genetic mutation in a gene on chromosome 7, most commonly the ΔF508 mutation, that codes for the cystic fibrosis transmembrane conductance regulator (CFTR) protein. This results in thicker mucus secretions and obstruction pathologies in multiple organs, including the lungs and sinuses.
Sinus disease and chronic...
241
Chest Physiotherapy01:24

Chest Physiotherapy

Chest Physiotherapy (CPT) is a therapeutic technique used in respiratory care to improve ventilation, clear bronchial secretions, and enhance the efficiency of respiratory muscles. This therapy includes three primary procedures: postural drainage, percussion, and vibration. It can be performed on spontaneously breathing patients and those who are intubated and mechanically ventilated.
Purpose
CPT is primarily used for patients with excessive bronchial secretions who have difficulty clearing...
888
Chronic Obstructive Pulmonary Disease-V: Management01:29

Chronic Obstructive Pulmonary Disease-V: Management

Managing Chronic Obstructive Pulmonary Disease (COPD) involves a multifaceted approach to reduce symptoms, prevent exacerbations, improve overall health status, and slow disease progression. Key strategies include lifestyle modifications, pharmacotherapy, supportive therapies, and, in some cases, surgery. Here is an overview of the primary COPD management strategies:
Smoking Cessation
2.7K
Cystic Fibrosis: Pathogenesis01:23

Cystic Fibrosis: Pathogenesis

Cystic fibrosis (CF), an autosomal recessive disorder, significantly affects the function of exocrine glands. This genetically inherited disease is characterized by the production of thick and sticky mucus, which can severely affect various organs and systems in the body.
CF is primarily caused by a genetic mutation in a chromosome 7 gene coding for the cystic fibrosis transmembrane conductance regulator (CFTR) protein. The most common gene mutation leading to CF is the ΔF508 mutation,...
401
Chronic Obstructive Pulmonary Disease-V: Nursing Management01:30

Chronic Obstructive Pulmonary Disease-V: Nursing Management

Nursing management of Chronic Obstructive Pulmonary Disease (COPD) is crucial for providing thorough care and support to patients. Nurses play an integral role in this process through detailed assessment, careful planning, targeted interventions, and ongoing evaluation. Here's an overview of the critical steps in nursing management for COPD.
Assessment
4.4K
Flail Chest-II01:26

Flail Chest-II

Managing flail chest, a condition characterized by a segment of the chest wall moving independently from the rest of the thoracic cage, requires a comprehensive approach. It includes a thorough assessment of the patient's condition, a diagnostic evaluation to determine the extent of the injury, and the implementation of appropriate medical interventions tailored to the individual's needs.
Assessment:
1. Clinical Evaluation:
History:
282